Zeenat Moorad Associate editor: Financial Mail

Fed up with the ever-rising prices Big Pharmas are charging for drugs, billionaire investor Warren Buffett, Amazon CEO Jeff Bezos and JPMorgan’s Jamie Dimon earlier this year said they would form an independent health-care company designed to bring down the cost of medicine and improve services for their employees. This Forbes headline was priceless: "Disruption, Thy Name is Bezos ... and Dimon and Buffett!" The jury is out on whether they can revolutionise American health care and figure out a way to deliver what the US government hasn’t ... or can’t. The trio, of course, have something else in common. They tend to use lengthy letter formats to (in equal measure) opine and dole out guidance about global events, management principles, investment strategy and other nuggets. Bezos’ annual shareholder letter is the second most-anticipated CEO missive of the year, behind the annual Berkshire Hathaway letter by Buffett — and it came out last week. Granted, when you’re the richest man in ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now